Armenía - enska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxo wellcome production - salbutamol (salbutamol sulfate) - solution pressurised inhalation - 100mcg/dose

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 1.2 mg/ml (equivalent: salbutamol, qty 1 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sulfuric acid - for the management of uncomplicated premature labour. to arrest labour between 24 and 33 weeks of gestation in patients with no medical or obstetric contraindication to tocolytic therapy. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 0.6 mg/ml (equivalent: salbutamol, qty 0.5 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sulfuric acid; water for injections - indications as at 3rd december 2002: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Singapúr - enska - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - salbutamol sulphate eqv salbutamol - injection - 5 mg/5 ml - salbutamol sulphate eqv salbutamol 5 mg/5 ml

Írland - enska - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salbutamol - concentrate for solution for infusion - 1 milligram(s)/millilitre - selective beta-2-adrenoreceptor agonists; salbutamol

Írland - enska - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salbutamol - solution for injection - 500 microgram(s)/millilitre - selective beta-2-adrenoreceptor agonists; salbutamol

Írland - enska - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salbutamol sulfate - oral solution - 2 mg/5ml - selective beta-2-adrenoreceptor agonists; salbutamol

Írland - enska - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salbutamol - inhalation powder, pre-dispensed - 200 microgram(s) - selective beta-2-adrenoreceptor agonists; salbutamol

Írland - enska - HPRA (Health Products Regulatory Authority)

ltt pharma limited - salbutamol sulfate - pressurised inhalation suspension - 100 microgram - selective beta-2-adrenoreceptor agonists

Írland - enska - HPRA (Health Products Regulatory Authority)

imbat limited - salbutamol sulfate - pressurised inhalation, suspension - 100 microgram(s) - selective beta-2-adrenoreceptor agonists; salbutamol